At BioCryst, advancing novel therapeutics for patients with complement-mediated and other rare diseases is our purpose. With our global presence, the work we do ...
People also ask
Is BioCryst a good stock to buy?
Is BioCryst a good company to work for?
What does BioCryst Pharmaceuticals do?
How many employees does BioCryst have?
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir... Wikipedia
BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases.
The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir (Rapivab) was approved ...
BCRX Stock Price - BioCryst Pharmaceuticals Inc. - MarketWatch
www.marketwatch.com › investing › bcrx
BCRX | Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Complete BioCryst Pharmaceuticals Inc. stock information by Barron's. View real-time BCRX stock price and news, along with industry-best analysis.
May 17, 2023 · We are a commercial-stage biotech company with US headquarters in Durham, North Carolina. Our European headquarters is in Dublin, Ireland, and ...
We develop oral small-molecule and protein therapeutics to target complement-mediated & other rare diseases. Community guidelines: https://t.co/HJsf9ax79K.